{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,22]],"date-time":"2026-04-22T15:58:17Z","timestamp":1776873497542,"version":"3.51.2"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2017,4,6]],"date-time":"2017-04-06T00:00:00Z","timestamp":1491436800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2017,4,6]],"date-time":"2017-04-06T00:00:00Z","timestamp":1491436800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Environmental and genetic risk factors are implicated in the pathogenesis of Alzheimer\u2019s disease (AD). However, how they interact and influence its pathogenesis remains to be investigated. High level of homocysteine (Hcy) is an AD risk factor and associates with an up-regulation of the ALOX5 gene. In the current paper we investigated whether this activation is responsible for the Hcy effect on the AD phenotype and the mechanisms involved. Triple transgenic mice were randomized to receive regular chow diet, a diet deficient in folate and B vitamins (Diet), which results in high Hcy, or the Diet plus zileuton, a specific ALOX5 inhibitor, for 7 months. Compared with controls, Diet-fed mice had a significant increase in Hcy levels, memory and learning deficits, up-regulation of the ALOX5 pathway, increased A\u03b2 levels, tau phosphorylation, and synaptic pathology, which were absent in mice treated with zileuton. <jats:italic>In vivo<\/jats:italic> and <jats:italic>vitro<\/jats:italic> studies demonstrated that the mechanism responsible was the hypomethylation of the ALOX5 promoter. Our findings demonstrate that the up-regulation of the ALOX5 is responsible for the Hcy-dependent worsening of the AD phenotype in a relevant mouse model of the disease. The discovery of this previously unknown cross-talk between these two pathways could afford novel therapeutic opportunities for treating or halting AD.<\/jats:p>","DOI":"10.1038\/srep46002","type":"journal-article","created":{"date-parts":[[2017,4,6]],"date-time":"2017-04-06T10:56:51Z","timestamp":1491476211000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":24,"title":["Five lipoxygenase hypomethylation mediates the homocysteine effect on Alzheimer\u2019s phenotype"],"prefix":"10.1038","volume":"7","author":[{"given":"Jian-Guo","family":"Li","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carlos","family":"Barrero","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Salim","family":"Merali","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Domenico","family":"Pratic\u00f2","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2017,4,6]]},"reference":[{"key":"BFsrep46002_CR1","doi-asserted-by":"crossref","unstructured":"Alzheimer\u2019s Association. 2016: Alzheimer\u2019s disease facts and figures. Alzheimer Dement. 12, 459\u2013509 (2016).","DOI":"10.1016\/j.jalz.2016.03.001"},{"key":"BFsrep46002_CR2","doi-asserted-by":"crossref","unstructured":"Giannopoulos, P. G. & Pratic\u00f2, D. Diet and Nutrition in Dementia and Cognitive Decline (Eds Martin, Colin R. & Reddy, Victor ) Chapter 2, 13\u201321 (Elsevier Publisher, London, UK, 2015).","DOI":"10.1016\/B978-0-12-407824-6.00002-1"},{"key":"BFsrep46002_CR3","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1146\/annurev-nutr-071715-050947","volume":"36","author":"AD Smith","year":"2016","unstructured":"Smith, A. D. & Refsum, H. Homocysteine, B Vitamins, and Cognitive Impairment. Annu Rev. Nutr. 36, 211\u2013239 (2016).","journal-title":"Annu Rev. Nutr."},{"key":"BFsrep46002_CR4","doi-asserted-by":"publisher","first-page":"562","DOI":"10.1016\/j.tips.2011.05.003","volume":"32","author":"JM Zhuo","year":"2011","unstructured":"Zhuo, J. M., Wang, H. & Pratic\u00f2, D. Is hyperhomocysteinemia an Alzheimer\u2019s disease (AD) risk factor, an AD marker, or neither? Trends Pharmacol. Sci. 32, 562\u2013571 (2011).","journal-title":"Trends Pharmacol. Sci."},{"key":"BFsrep46002_CR5","doi-asserted-by":"publisher","first-page":"777","DOI":"10.3233\/JAD-150140","volume":"46","author":"L Shen","year":"2015","unstructured":"Shen, L. & Ji, H. F. Association between homocysteine, folic acid, vitamin B12 and Alzheimer\u2019s disease: insights from meta-analysis. J. Alz. Dis. 46, 777\u2013790 (2015).","journal-title":"J. Alz. Dis."},{"key":"BFsrep46002_CR6","first-page":"160","volume":"7","author":"EH Mizrahi","year":"2003","unstructured":"Mizrahi, E. H. et al. Plasma total homocysteine levels, dietary vitamin B6 and folate intake in AD and healthy aging. J. Nutr. Health Aging 7, 160\u2013165 (2003).","journal-title":"J. Nutr. Health Aging"},{"key":"BFsrep46002_CR7","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1002\/cphy.c150021","volume":"6","author":"KS McCully","year":"2015","unstructured":"McCully, K. S. Homocysteine Metabolism, Atherosclerosis, and Diseases of Aging. Compr. Physiol. 6, 471\u2013505 (2015).","journal-title":"Compr. Physiol."},{"key":"BFsrep46002_CR8","doi-asserted-by":"publisher","first-page":"140","DOI":"10.2174\/156720510790691326","volume":"7","author":"JM Zhuo","year":"2010","unstructured":"Zhuo, J. M. et al. Diet-induced hyperhomocysteinemia increases amyloid-beta formation and deposition in a mouse model of Alzheimer\u2019s disease. Curr. Alzheimer Res. 7, 140\u2013149 (2010).","journal-title":"Curr. Alzheimer Res."},{"key":"BFsrep46002_CR9","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1016\/j.nbd.2006.01.005","volume":"22","author":"J Pacheco-Quinto","year":"2006","unstructured":"Pacheco-Quinto, J. et al. Hyperhomocysteinemic Alzheimer\u2019s mouse model of amyloidosis shows increased brain amyloid beta peptide levels. Neurobiol. Dis. 22, 651\u2013656 (2006).","journal-title":"Neurobiol. Dis."},{"key":"BFsrep46002_CR10","doi-asserted-by":"publisher","first-page":"3895","DOI":"10.1096\/fj.10-161828","volume":"24","author":"J Zhuo","year":"2010","unstructured":"Zhuo, J. & Pratic\u00f2, D. Normalization of hyperhomocysteinemia improves cognitive deficits and ameliorates brain amyloidosis of a transgenic mouse model of Alzheimer\u2019s disease. FASEB J. 24, 3895\u20133902 (2010).","journal-title":"FASEB J"},{"key":"BFsrep46002_CR11","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1002\/ana.24145","volume":"75","author":"JG Li","year":"2014","unstructured":"Li, J. G., Chu, J., Barrero, C., Merali, S. & Pratic\u00f2, D. Homocysteine exacerbates A\u03b2, tau pathology and cognitive deficit in a mouse model of Alzheimer\u2019s with plaques and tangles. Ann. Neurol. 75, 851\u2013863 (2014).","journal-title":"Ann. Neurol."},{"key":"BFsrep46002_CR12","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1111\/acel.12550","volume":"16","author":"JG Li","year":"2017","unstructured":"Li, J. G. et al. Homocysteine modulates 5Lipoxygenase expression level via DNA methylation. Aging Cell 16, 273\u2013280 (2017).","journal-title":"Aging Cell"},{"key":"BFsrep46002_CR13","doi-asserted-by":"publisher","first-page":"1169","DOI":"10.1096\/fj.07-9131.com","volume":"22","author":"O Firuzi","year":"2008","unstructured":"Firuzi, O., Zhuo, J., Chinnici, C. M., Wisniewski, T. & Pratic\u00f2, D. 5-Lipoxygenase gene disruption reduces amyloid-{beta} pathology in a mouse model of Alzheimer\u2019s disease. FASEB J 22, 1169\u20131178 (2008).","journal-title":"FASEB J"},{"key":"BFsrep46002_CR14","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1002\/ana.22234","volume":"69","author":"J Chu","year":"2011","unstructured":"Chu, J. & Pratic\u00f2, D. 2011. 5-Lipoxygenase as an endogenous modulator of amyloid beta formation in vivo . Ann. Neurol. 69, 34\u201346 (2011).","journal-title":"Ann. Neurol."},{"key":"BFsrep46002_CR15","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1002\/ana.23642","volume":"72","author":"J Chu","year":"2012","unstructured":"Chu, J., Giannopoulos, P. F., Ceballos-Diaz, C., Golde, T. E. & Pratic\u00f2, D. 5-Lipoxygenase gene transfer worsens memory, amyloid and tau brain pathologies in a mouse model of Alzheimer disease. Ann. Neurol. 72, 442\u2013454 (2012).","journal-title":"Ann. Neurol."},{"key":"BFsrep46002_CR16","doi-asserted-by":"publisher","first-page":"e70991","DOI":"10.1371\/journal.pone.0070991","volume":"3","author":"J Chu","year":"2013","unstructured":"Chu, J., Li, J. G. & Pratic\u00f2, D. Zileuton improves memory deficits, amyloid and tau pathology in a mouse model of Alzheimer\u2019s disease with plaques and tangles. PLoS ONE 3, 8(8), e70991 (2013).","journal-title":"PLoS ONE"},{"key":"BFsrep46002_CR17","doi-asserted-by":"publisher","first-page":"747","DOI":"10.3233\/JAD-150977","volume":"52","author":"Q Hu","year":"2016","unstructured":"Hu, Q., Teng, W., Li, J., Hao, F. & Wang, N. Homocysteine and Alzheimer\u2019s disease: evidence for a causal link from mendelian randomization. J. Alz. Dis. 52, 747\u2013756 (2016).","journal-title":"J. Alz. Dis."},{"key":"BFsrep46002_CR18","doi-asserted-by":"publisher","first-page":"503","DOI":"10.3233\/JAD-150458","volume":"49","author":"K Miwa","year":"2015","unstructured":"Miwa K. et al. Increased total homocysteine levels predict the risk of incident dementia independent of cerebral small-vessel diseases and vascular risk factors. J. Alz. Dis. 49, 503\u2013513 (2015).","journal-title":"J. Alz. Dis."},{"key":"BFsrep46002_CR19","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1111\/bcpt.12424","volume":"17","author":"M Sharma","year":"2015","unstructured":"Sharma, M., Tiwari, M. & Tiwari, R. K. Hyperhomocysteinemia: impact on neurodegenerative diseases. Basic Clin. Pharmacol. Toxicol. 17, 287\u2013296 (2015).","journal-title":"Basic Clin. Pharmacol. Toxicol."},{"key":"BFsrep46002_CR20","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1016\/j.neubiorev.2016.08.014","volume":"69","author":"E Seti\u00e9n-Suero","year":"2016","unstructured":"Seti\u00e9n-Suero, E., Su\u00e1rez-Pinilla, M., Su\u00e1rez-Pinilla, P., Crespo-Facorro, B. & Ayesa-Arriola, R. Homocysteine and cognition: A systematic review of 111 studies. Neurosci. Biobehav. Rev. 69, 280\u2013298 (2016).","journal-title":"Neurosci. Biobehav. Rev."},{"key":"BFsrep46002_CR21","doi-asserted-by":"crossref","unstructured":"Aisen, P. et al. High dose B vitamin supplementation and cognitive decline in Alzheimer\u2019s disease: a randomized controlled trial. JAMA 300, 1774\u20131783 (2008).","DOI":"10.1001\/jama.300.15.1774"},{"key":"BFsrep46002_CR22","doi-asserted-by":"publisher","first-page":"1020","DOI":"10.1001\/jama.2009.211","volume":"301","author":"D Pratico","year":"2009","unstructured":"Pratico, D. High-dose B vitamin supplements and Alzheimer disease. JAMA 301, 1020\u20131021 (2009).","journal-title":"JAMA"},{"key":"BFsrep46002_CR23","doi-asserted-by":"publisher","first-page":"2994","DOI":"10.1016\/j.febslet.2006.04.088","volume":"580","author":"R Obeid","year":"2006","unstructured":"Obeid, R. & Herrmann, W. Mechanisms of homocysteine neurotoxicity in neurodegenerative diseases with special reference to dementia. FEBS Lett. 580, 2994\u20133005 (2006).","journal-title":"FEBS Lett."},{"key":"BFsrep46002_CR24","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1093\/nutrit\/nuv022","volume":"73","author":"A McCaddon","year":"2015","unstructured":"McCaddon, A. & Miller, J. W. Assessing the association between homocysteine and cognition: reflections on Bradford Hill, meta-analyses and causality. Nutr. Rev. 73, 723\u2013735 (2015).","journal-title":"Nutr. Rev."},{"key":"BFsrep46002_CR25","doi-asserted-by":"publisher","first-page":"2811","DOI":"10.1093\/jn\/131.11.2811","volume":"131","author":"MA Caudill","year":"2001","unstructured":"Caudill, M. A. et al. Intracellular S-adenosylhomocysteine concentrations predict global DNA hypomethylation in tissues of methyl-deficient cystathionine beta-synthase heterozygous mice. J. Nutr. 131, 2811\u20132818 (2001).","journal-title":"J. Nutr."},{"key":"BFsrep46002_CR26","doi-asserted-by":"publisher","first-page":"831","DOI":"10.1007\/s00109-005-0679-8","volume":"83","author":"R Castro","year":"2005","unstructured":"Castro, R. et al. Intracellular S-adenosylhomocysteine increased levels are associated with DNA hypomethylation in HUVEC. J. Mol. Med. 83, 831\u2013836 (2005).","journal-title":"J. Mol. Med."},{"key":"BFsrep46002_CR27","doi-asserted-by":"publisher","first-page":"4374","DOI":"10.1074\/jbc.M107665200","volume":"277","author":"J Uhl","year":"2002","unstructured":"Uhl, J. et al. The 5-lipoxygenase promoter is regulated by DNA methylation. J. Biol. Chem. 277, 4374\u20134379 (2002).","journal-title":"J. Biol. Chem."},{"key":"BFsrep46002_CR28","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1016\/j.bcp.2013.11.005","volume":"88","author":"PF Giannopoulos","year":"2014","unstructured":"Giannopoulos, P. F., Joshi, Y. B. & Pratic\u00f2, D. Novel lipid signaling pathways in Alzheimer\u2019s disease pathogenesis. Biochem. Pharmacol. 88, 560\u2013564 (2014).","journal-title":"Biochem. Pharmacol."},{"key":"BFsrep46002_CR29","doi-asserted-by":"publisher","first-page":"2458","DOI":"10.1016\/j.neurobiolaging.2014.05.016","volume":"35","author":"A Di Meco","year":"2014","unstructured":"Di Meco, A., Lauretti, E., Vagnozzi, A. & Pratic\u00f2, D. Zileuton restores memory impairments and reverses amyloid and tau pathology in aged AD mice. Neurobiol. Aging 35, 2458\u20132464 (2014).","journal-title":"Neurobiol. Aging"},{"key":"BFsrep46002_CR30","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1038\/mp.2013.23","volume":"19","author":"PF Giannopoulos","year":"2014","unstructured":"Giannopoulos, P. F. et al. Gene knockout of 5-lipoxygenase rescues synaptic dysfunction and improves memory in the triple-transgenic model of Alzheimer\u2019s disease. Mol. Psychiatry. 19, 511\u2013518 (2014).","journal-title":"Mol. Psychiatry."},{"key":"BFsrep46002_CR31","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1016\/j.biopsych.2015.01.015","volume":"78","author":"PF Giannopoulos","year":"2015","unstructured":"Giannopoulos, P. F. et al. Pharmacologic inhibition of 5-lipoxygenase improves memory, rescues synaptic dysfunction, and ameliorates tau pathology in a transgenic model of tauopathy. Biol. Psychiatry 78, 693\u2013701 (2015).","journal-title":"Biol. Psychiatry"},{"key":"BFsrep46002_CR32","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1016\/S0896-6273(03)00434-3","volume":"39","author":"S Oddo","year":"2003","unstructured":"Oddo, S. et al. Triple transgenic model of Alzheimer\u2019s disease with plaques and tangles: intracellular Abeta and synaptic dysfunction. Neuron 39, 409\u2013421 (2003).","journal-title":"Neuron"},{"key":"BFsrep46002_CR33","doi-asserted-by":"publisher","first-page":"6894","DOI":"10.1093\/hmg\/ddu412","volume":"23","author":"YB Joshi","year":"2014","unstructured":"Joshi, Y. B. et al. Absence of ALOX5 gene prevents stress-induced memory deficits, synaptic dysfunction and tauopathy in a mouse model of Alzheimer\u2019s disease. Hum. Mol. Genet. 23, 6894\u20136902 (2014).","journal-title":"Hum. Mol. Genet."},{"key":"BFsrep46002_CR34","doi-asserted-by":"publisher","first-page":"7690","DOI":"10.1074\/jbc.M709399200","volume":"283","author":"CA Moncada","year":"2008","unstructured":"Moncada, C. A., Clarkson, A., Perez-Leal, O. & Merali, S. Mechanism and tissue specificity of nicotine-mediated lung D-adenosylmethionine reduction. J. Biol. Chem. 283, 7690\u20137696 (2008).","journal-title":"J. Biol. Chem."},{"key":"BFsrep46002_CR35","doi-asserted-by":"publisher","first-page":"1267","DOI":"10.1016\/S0140-6736(03)12984-4","volume":"361","author":"M Skelly","year":"2003","unstructured":"Skelly, M. et al. S-adenosylmethionine concentrations in diagnosis of Pneumocystis carini pneumonia. Lancet 361, 1267\u20131268 (2003).","journal-title":"Lancet"},{"key":"BFsrep46002_CR36","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1002\/ana.22625","volume":"71","author":"J Chu","year":"2012","unstructured":"Chu, J., Zhuo, J. M. & Pratic\u00f2, D. Transcriptional regulation of \u03b2 secretase-1 by 12\/15-Lipoxygenase results in enhanced amyloidogenesis and cognitive impairments. Ann. Neurol. 71, 57\u201367 (2012).","journal-title":"Ann. Neurol."},{"key":"BFsrep46002_CR37","doi-asserted-by":"crossref","unstructured":"Dzitoyeva, S., Imbesi, M., Ng, L. W. & Manev, H. 5-Lipoxygenase DNA Methylation and mRNA Content in the Brain and Heart of Young and Old Mice. Neural Plasticity 209596 (2009).","DOI":"10.1155\/2009\/209596"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/srep46002.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/srep46002","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/doifinder\/10.1038\/srep46002","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/www.nature.com\/articles\/srep46002.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,23]],"date-time":"2022-12-23T18:23:18Z","timestamp":1671819798000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/srep46002"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,4,6]]},"references-count":37,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2017,5,31]]}},"alternative-id":["BFsrep46002"],"URL":"https:\/\/doi.org\/10.1038\/srep46002","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,4,6]]},"assertion":[{"value":"25 January 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 March 2017","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 April 2017","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing financial interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"46002"}}